MASI Add to watchlist $178.45 +0.00 (+0.00%) Last updated: May 31, 2026 03:43
52-Week Range
$178.45
$125.94 $178.45 $179.00

Fundamentals Overview

Masimo Corporation is near the high of its 52-week range with premium valuation, trading relatively flat today.

Valuation premium

P/E 123 PEG 1.07 P/B 11.81 P/S 6

Intrinsic value (DCF)

-82.4% downside vs price

Profitability

Net margin 4.9%

Risk (Beta)

1.13 — in line vol

Earnings & growth

EPS $1.45 Rev -2.2% Profit -16.4% vs prior qtr

BullzEye Analysis

Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell
Buy
Hold — 59% confidence Risk: Moderate Volatility — Beta 1.13. Diversify and only invest what you can afford to lose.

Supporting (Buy):

Analyst grade: B- · 3M vs Healthcare sector: +7.2%

Pressures (Sell):

DCF 82.4% downside vs price · 3M vs S&P 500: -7.2%

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap
$9.34B
P/E (TTM)
123.02
EPS (TTM)
$1.45
Dividend Yield
N/A
52-Week Range
$125.94 - $179.00
Volume vs Avg
N/A
Beta
1.13

About

Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, incl...
Sector: Healthcare
Headquarters: US
Employees: 3,600
IPO Date: Aug 2007
Beta: 1.13 (More volatile than market)

Ratings & Grades at a Glance

Overall rating: B-. Recent institutional grades: mixed. Current institutional positions: Buy: 7, Equal Weight: 1, Hold: 4, Market Perform: 1, Neutral: 2, Outperform: 3, Overweight: 12.

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

DCF vs price: DCF estimate is $31.42; current price is $178.45. That’s a -82.4% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.

Metric Value
Valuation
P/E (TTM) 123.02
DCF value (model) $31.42 (-82.4% vs price)
PEG (TTM) 1.07
P/B (TTM) 11.81
P/S (TTM) 6
P/FCF (TTM) 44.75
Liquidity & enterprise
Current Ratio (TTM) 2.68
Quick Ratio (TTM) 1.45
Cash Ratio (TTM) 0.38
Profitability
ROE (TTM) N/A
ROA (TTM) N/A
Revenue growth (YoY) N/A
Net margin (TTM) 4.9%
Gross margin (TTM) 61.73%
Operating margin (TTM) 19.85%
Debt to equity (TTM) N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for MASI.

Analyst Sentiment at a Glance

B- Sentiment Mixed
Buy 7Equal Weight 1Hold 4Market Perform 1Neutral 2Outperform 3Overweight 12
3 upgrades, 3 downgrades
Price Target Consensus
Current $178.45
Median $185.00
Consensus $187.50
Low consensus $180.00
High consensus $200.00

Stock Grades (Institutions)

Institution Action Previous Grade New Grade Date
Raymond James downgrade Outperform Market Perform 2026-03-27
BTIG downgrade Buy Neutral 2026-02-18
Wells Fargo downgrade Overweight Equal Weight 2026-02-18
BTIG maintain Buy Buy 2025-12-04
BTIG maintain Buy Buy 2025-11-24
BTIG maintain Buy Buy 2025-11-05
Wells Fargo maintain Overweight Overweight 2025-11-05
BTIG maintain Buy Buy 2025-09-11
Piper Sandler maintain Overweight Overweight 2025-08-06
Wells Fargo maintain Overweight Overweight 2025-05-07
Piper Sandler maintain Overweight Overweight 2025-05-07
Raymond James maintain Outperform Outperform 2025-05-07
Needham maintain Hold Hold 2025-04-10
Needham maintain Hold Hold 2025-02-26
Piper Sandler maintain Overweight Overweight 2025-02-26
Wells Fargo maintain Overweight Overweight 2025-02-26
Needham maintain Hold Hold 2025-01-22
Needham maintain Hold Hold 2025-01-16
Raymond James maintain Outperform Outperform 2024-12-27
Piper Sandler maintain Overweight Overweight 2024-12-18
Wells Fargo maintain Overweight Overweight 2024-12-11
Stifel maintain Buy Buy 2024-11-22
Wells Fargo maintain Overweight Overweight 2024-11-06
Piper Sandler maintain Overweight Overweight 2024-11-06
Raymond James upgrade Market Perform Outperform 2024-11-06
BTIG maintain Buy Buy 2024-10-14
Piper Sandler maintain Overweight Overweight 2024-08-07
Piper Sandler upgrade Neutral Overweight 2024-06-03
Piper Sandler maintain Neutral Neutral 2024-05-08
Stifel upgrade Hold Buy 2024-04-15